Comparative Field Study: Impact of Laboratory Assay Variability on the Assessment of Recombinant Factor IX Fc Fusion Protein (rFIXFc) Activity

Thrombosis and Haemostasis - Germany
doi 10.1160/th13-11-0971
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Prolonged Activity of Factor IX as a Monomeric Fc Fusion Protein

Blood
BiochemistryImmunologyCell BiologyHematology
2010English

Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice

PLoS ONE
Multidisciplinary
2016English

Evaluation of the Toxicology and Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein in Animals

Thrombosis Research
Hematology
2015English

Performance of a Recombinant Fusion Protein Linking Coagulation Factor IX With Recombinant Albumin in One-Stage Clotting Assays

Journal of Thrombosis and Haemostasis
MedicineHematology
2018English

Indirect Comparison of the Efficacy of Recombinant Factor Viii Fc Fusion Protein and Other Factor Viii Products for ProphylaxisModeling the Effect of Compliance

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Predicting FVIII Activity in Patients Who Use Recombinant FVIII Fc Fusion Protein for Prophylaxis and Treatment of Bleeding Episodes

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

The Recombinant Expression and Activity Detection of MAF-1 Fusion Protein

Scientific Reports
Multidisciplinary
2015English

A Single Chain Variant of Factor VIII Fc Fusion Protein Retains Normal in Vivo Efficacy but Exhibits Altered in Vitro Activity

PLoS ONE
Multidisciplinary
2014English

Expression of Recombinant Factor IX Using the Transient Gene Expression Technique

Research in Molecular Medicine (RMM)
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy